Nitric oxide involved in the IL-1-induced inhibition of fructose intestinal transport

Journal of Cellular Biochemistry

Volumn 111, Issue 5, 2010, Pages 1321-1329

  García Barrios, Alberto ^a,b   Guillén, Natalia ^a,b   Gascõn, Sonia ^a,b   Osada, Jesús ^a,b   Vazquez, Carmen Ma ^c   Miguel Carrasco, José Luis ^c   Rodríguez Yoldi, Ma Jesús ^a,b  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

fructose; GLUT5; IL 1 ; intestinal transport; NO; prostaglandins; rabbit

Indexed keywords

GLUCOSE TRANSPORTER 5; INDOMETACIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; RECOMBINANT INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BODY TEMPERATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIUM CELL; HEXOSE TRANSPORT; INTESTINE ABSORPTION; INTESTINE BRUSH BORDER MEMBRANE; JEJUNUM; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL TRANSPORT; FRUCTOSE; GLUCOSE TRANSPORTER TYPE 5; INTERLEUKIN-1BETA; INTESTINAL ABSORPTION; JEJUNUM; NITRIC OXIDE; RABBITS; SHOCK, SEPTIC;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 78649853559     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22859     Document Type: Article

References (50)

1. Abad B, Mesonero JE, Salvador MT, García-Herrera J, Rodríguez-Yoldi MJ,. 2001a. Effect of lipopolysaccharide on small intestinal L -leucine transport in rabbit. Dig Dis Sci 46: 1113-1119.
2. Abad B, Mesonero JE, Salvador MT, García-Herrera J, Rodríguez-Yoldi MJ,. 2001b. The administration of lipopolysaccharide, in vivo, induces alteration in L -leucine intestinal absorption. Life Sci 70: 615-618.
3. Abad B, Mesonero JE, Salvador MT, García-Herrera J, Rodríguez-Yoldi MJ,. 2002a. Cellular mechanism underlying LPS-induced inhibition of in vitro L -leucine transport across rabbit jejunum. J Endotox Res 8: 127-133.
4. Abad B, Mesonero JE, Salvador MT, García-Herrera J, Rodríguez-Yoldi MJ,. 2002b. Tumor necrosis factor-α mediates inhibitory effect of lipopolysaccharide on L -leucine intestinal uptake. Dig Dis Sci 46: 1316-1322.
5. Al-Sadi RM, Ma TY,. 2007. IL-1β causes an increase in intestinal epithelial tight junction permeability. J Immunol 178: 4641-4649.
6. Amador P, García-Herrera J, Marca MC, de la Osada J, Acín S, Navarro MA, Salvador MT, Lostao MP, Rodríguez-Yoldi MJ,. 2007a. Intestinal D -galactose transport in an endotoxemia model in the rabbit. J Membr Biol 215: 125-133.
7. Amador P, García-Herrera J, Marca MC, de la Osada J, Acín S, Navarro MA, Salvador MT, Lostao MP, Rodríguez-Yoldi MJ,. 2007b. Inhibitory effect of TNF-α on the intestinal absorption of galactose. J Cell Biochem 101: 99-111.
8. Amador P, Marca MC, García-Herrera J, Lostao MP, Gillén N, de la Osada J, Rodríguez-Yoldi MJ,. 2008. Lipopolysaccharide induces inhibition of galactose intestinal transport in rabbits in vitro. Cell Physiol Biochem 22: 715-724.
9. Arbonés-Mainar JM, Navarro MA, Acín S, Guzmán MA, Arnal C, Surra JC, Carnicer R, Roche HM, Osada J,. 2006. Trans-10, cis-12- and cis-9, trans-11 conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice. J Nutr 136 (2): 353-359.
10. Bachmann MF, Kopf M,. 2002. Balancing protective immunity and immunopathology. Curr Opin Immunol 14 (4): 413-419.
11. Backlund MG, Mann JR, Holla VR, Buchanan FG, Tai HH, Musiek ES, Milne GL, Katkuri S, DuBois RN,. 2005. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. J Biol Chem 280: 3217-3223.
12. +-activated D-glucose transport systems in guinea pig jejunal brush border membrane vesicles. J Biol Chem 261: 6168-6176.
13. Burant CF, Takeda J, Brot-Laroche E, Bell GI, Davidson NO,. 1992. Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem 267: 14523-14526.
14. Chang EB, Musch MW, Mayer L,. 1990. Interleukin 1 and 3 stimulate anion secretion in chicken intestine. Gastroenterology 98: 1518-1524.
15. Charles A, Dinarello MD,. 1988. Interleukin-1. Dig Dis Sci 33 (3): 25S-35S.
16. Chiossone DC, Simon PL, Smith PL,. 1990. Interleukin-1: Effects on rabbit ileal mucosal ion transport in vitro. Eur J Pharmacol 180: 217-228.
17. Church LD, Cook GP, McDermott MF,. 2007. Nature clinical practice. Rheumatology 4 (2): 34-42 (Review).
18. Dinarello CA,. 1988. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann NY Acad Sci 856: 1-11.
19. Dinarello CA,. 2005. Interleukin-1β. Crit Care Med 33 (12): S460-S462.
20. Dinarello CA,. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27: 519-550.
21. García-Herrera J, Abad B, Rodríguez-Yoldi MJ,. 2003. Effect of lipopolysaccharide on D -fructose transport across rabbit jejunum. Inflamm Res 52: 177-184.
22. García-Herrera J, Navarro MA, Marca MC, De la Osada J, Rodríguez-Yoldi MJ,. 2004. The effect of tumor necrosis factor-α on D -fructose intestinal transport in rabbits. Cytokine 25: 21-30.
23. García-Herrera J, Marca MC, Brot-Laroche E, Guillén N, Acín S, Navarro MA, De la Osada J, Rodríguez-Yoldi MJ,. 2007. Protein kinases, TNF-α, and proteasome contribute in the inhibition of fructose intestinal transport by sepsis in vivo. Am J Physiol Gastrointest Liver Physiol 294: G155-G164.
24. Hardin J, Kroeker K, Chung B, Gall DG,. 2000. Effect of proinflammatory interleukins on jejunal nutrient transport. Gut 47: 184-191.
25. Helliwell PA, Richardson M, Affleck J, Kellet GL,. 2000. Regulation of GLUT5, GLUT2 and intestinal brush-border fructose absorption by the extracellular signal-regulated kinase, p38 mitogen-activated kinase and phosphatidylinositol 3-kinase intracellular signaling pathways. Biochem J 350: 163-169.
26. 2-activated housekeeping Cl- channels in the basolateral membrane of rat gastric parietal cells. Jpn J Physiol 49: 365-372.
27. Jergens AE,. 1999. Inflammatory bowel disease. Current Perspectives. Vet Clin North Am Small Anim Pract 29 (2): 501-521.
28. Jourd'Hevil D, Morise Z, Conner EM, Grisham MB,. 1997. Oxidants, transcription factors, and intestinal inflammation. J Clin Gastroenterol 25 (1): 561-572.
29. Kellet GL, Brot-Laroche E,. 2005. Apical GLUT2: A major pathway of intestinal sugar absorption. Diabetes 54: 3056-3062.
30. Kellet GL, Brot-Laroche E, Mace OJ, Letunque A,. 2008. Sugar absorption in the intestine: The role of GLUT2. Annu Rev Nutr 28: 35-54.
31. Kreydiyyeh SI, Haddad JJE, Garabedian B-S,. 1998. Interleukin-1 beta inhibits the intestinal transport of [14C] 3-o-methylglucose in the rat. Life Sci 63 (21): 1913-1919.
32. Kone BC, Kuncewicz T, Ahang W, Yu Z-Y,. 2003. Protein interactions with nitric oxide synthases: Controlling the right time, the right place, and the right amount of nitric oxide. Am J Physiol Renal Physiol 285: F178-F190.
33. Le Gall M, Tobin V, Stolarczyk E, Dalet V, Leturque A, Brot-Laroche E,. 2007. Sugar Sensing by enterocytes combines polarity, membrane bound detectors and sugar metabolism. J Cell Physiol 213: 834-843.
34. Leturque A, Brot-Laroche E, Le Gall M,. 2009. GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab 296: E985-E992.
35. Lewis SA, Berg JR, Kleine TJ,. 1995. Modulation of epithelial permeability by extracellular macromolecules. Physiol Rev 75: 561-589.
36. McKay DM, Baird AW,. 1999. Cytokine regulation of epithelial permeability and ion transport. Gut 44: 283-289.
37. Mesonero J, Matosin M, Cambier D, Rodríguez-Yoldi MJ, Brot-Laroche E,. 1995. Sugar-dependent expression of the fructose transporter GLUT5 in Caco-2 cells. Biochem J 312: 757-762.
38. Metzger S, Nusair S, Planer D, Barash V, Pappo O, Shilyansky J, Chajek-Shaul T,. 2004. Inhibition of hepatic gluconeogenesis and enhanced glucose uptake contribute to the development of hypoglycaemia in mice bearing interleukin-1beta-secreting tumor. Endocrinology 145 (11): 5150-5156.
39. O'Neill GP, Ford-Hutchinson AW,. 1993. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS 330: 156-160.
40. Opal SM,. 2007. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol 297: 365-377.
41. Opp MR, Krueger JM,. 1991. Interleukin-1 receptor antagonist blocks interleukin-1-induced sleep and fever. Am J Physiol 260: R453-R457.
42. Powanda MC, Beisel WR,. 2003. Metabolic effects of infection on protein and energy status. J Nutr 133 (1): 322S-327S.
43. Riedemann NC, Guo RF, Hollmann TJ, Gao H, Neff TA, Reuben JS, Speyer CL, Sarma JV, Wetsel RA, Zetoune FS, Ward PA,. 2004. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J 18 (2): 370-372.
44. Sears C, Kaper J,. 1996. Enteric bacterial toxins: Mechanisms of action and link-age to intestinal secretion. Microbiol Rev 60: 167-215.
45. Takeuchi K, Tanaka A, Ohno R, Yokota A,. 2003. Role of Cox inhibition in pathogenesis of NSAID-induced small intestinal damage. J Physiol Pharmacol 54 (4): 165-182.
46. Wallace JL, Devchand PR,. 2005. Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense. Brit J Pharmacol 145: 275-282.
47. Weinberg JR, Wright DJM, Guz A,. 1988. Interleukin-1 and tumor necrosis factot cuse hypotension in the conscious rabbit. Clin Sci 75: 251-255.
48. Xu R, Morales JA, Muniyappa R, Skafar DF, Ram JL, Sowers JR,. 1999. Interleukin-1beta-induced nitric oxide production in rat aortic endothelial cells: Inhibition by estradiol in normal and high glucose cultures. Life Sci 64: 2451-2462.
49. Yamashiro O, Morimoto A, Sakata Y, Watanabe T, Murukami N,. 1993. Febrile and metabolic tolerante to endotoxin and human recombinant interleukin-1 beta in rabbits. Am J Physiol Regul Integr Comp Physiol 264: R1180-R1185.
50. Yoon DY, Dinarello CA,. 2007. Differential effects of anti-IL-1R accessory protein antibodies on IL-1alpha or IL-1beta-induced production of PGE(2) and IL-6 from 3T3-L1 cells. J Biochem Mol Biol 40 (4): 562-570.